Abstract

Background: Undetected depression can result in a significant decline in productivity among the workforce in every system, the healthcare sector inclusive. It is vital to utilize brief screening tools to detect populations at risk of depression. The 5-item WHO Well-being Index (WHO-5) has been used as a screening measure for depression, but research on this is scarce in sub-Saharan Africa. This study aimed to determine the utility and validity of the WHO-5 in screening for depression in a population of doctors and nurses in Nigeria during the COVID-19 pandemic. Methods: A representative sample of medical doctors and nurses across Nigeria (n = 464), completed the 5-item World Health Organization Well-Being Index (WHO-5) and the 9-item Patient Health Questionnaire (PHQ-9). Results: The pattern of factors associated with cases of a positive depression screening was considerably similar for the WHO-5 and the PHQ-9. At a cut-off score of 50 for the WHO-5, the sensitivity and specificity values obtained were 0.857 and 0.851 respectively. Positive and negative predictive values were 0.404 and 0.981 respectively. ROC analysis of the WHO-5 against the PHQ-9 revealed that, at a cut-off of 50, the sensitivity of the WHO-5 was 0.857, 1-specificity was 0.152. The AUC was 0.918 (95% CI 0.884-0.953). Also, there was a strong, negative correlation between the WHO and the PHQ-9 scores (r = -0.590, p ≤ 0.0001). Conclusion: The WHO-5 well-being index has satisfactory validity as a screening tool for the detection of depression. It is also feasible for use in very busy settings, because of its brevity and ease of administration.

Highlights

  • Undetected depression can result in a significant decline in productivity among the workforce in every system, the healthcare sector inclusive

  • Health care professionals (HCPs), such as doctors and nurses under the demanding nature of their work are confronted with a great risk of mental health challenges which may exacerbate or precipitate depressive disorder and other mental illnesses (Pappa et al, 2020; Salari et al, 2020; Vizheh et al, 2020)

  • The optimal cut-off score of 10, yielded a prevalence of 10.6% positive screen for depression using the PHQ-9 (n = 49), corresponding with moderate to severe levels of depression

Read more

Summary

Introduction

Undetected depression can result in a significant decline in productivity among the workforce in every system, the healthcare sector inclusive. This study aimed to determine the utility and validity of the WHO-5 in screening for depression in a population of doctors and nurses in Nigeria during the COVID-19 pandemic. Results: The pattern of factors associated with cases of a positive depression screening was considerably similar for the WHO-5 and the PHQ-9. Conclusion: The WHO-5 well-being index has satisfactory validity as a screening tool for the detection of depression. It is feasible for use in very busy settings, because of its brevity and ease of administration. The consequences of undetected and untreated depression in HCPs confer a huge burden on the health care system and may invariably determine the efficiency of the system, as well as the health outcomes of the patients (Williams et al, 2017)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call